Viagra not universal 'cure-all' for impotency
If you are suffering from impotence or erectile dysfunction, reaching out for Viagra and other related drugs may help you increase the levels of your sexual activity, but not satisfaction, suggests a new research.
Moreover, people suffering from erectile dysfunction have higher odds of suffering from high blood pressure and diabetes.
Viagra and other related drugs, clinically known as oral phosphodiesterase type 5 inhibitors (PDE5i), cannot address these associated concerns, the researchers pointed out, suggesting that restoring erectile dysfunction (ED) pharmacologically is not a 'cure-all'.
"It is important that health professionals act on this and offer a more rounded approach to managing ED," said lead author of the study David Lee from the University of Manchester in Britain.
This should include a well-informed patient with realistic expectations, support from his partner, and an improved assessment of any psychological or relationship issues that may exacerbate sexual concerns and dissatisfaction, Lee pointed out.
The researchers studied the responses of more than 2,600 English men aged 50-87 years.
Older men who had recently used PDE5i drugs reported higher levels of sexual activity and function than men without ED, but were more likely to be concerned and/or dissatisfied with their sex lives.
Moreover, people suffering from erectile dysfunction have higher odds of suffering from high blood pressure and diabetes.
Viagra and other related drugs, clinically known as oral phosphodiesterase type 5 inhibitors (PDE5i), cannot address these associated concerns, the researchers pointed out, suggesting that restoring erectile dysfunction (ED) pharmacologically is not a 'cure-all'.
This should include a well-informed patient with realistic expectations, support from his partner, and an improved assessment of any psychological or relationship issues that may exacerbate sexual concerns and dissatisfaction, Lee pointed out.
The researchers studied the responses of more than 2,600 English men aged 50-87 years.
Older men who had recently used PDE5i drugs reported higher levels of sexual activity and function than men without ED, but were more likely to be concerned and/or dissatisfied with their sex lives.
